Literature DB >> 2496814

Treating mild hypertension. Report of the British Hypertension Society working party.

.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2496814      PMCID： PMC1836038          DOI： 10.1136/bmj.298.6675.694

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  16 in total

1.  Treatment of mild hypertension: results of a ten-year intervention trial.

Authors:  W M Smith
Journal:  Circ Res       Date:  1977-05       Impact factor: 17.367

2.  Lowering blood pressure.

Authors:  J Coope; T S Warrender
Journal:  Lancet       Date:  1987-06-13       Impact factor: 79.321

3.  Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study.

Authors:  J Wikstrand; I Warnold; G Olsson; J Tuomilehto; D Elmfeldt; G Berglund
Journal:  JAMA       Date:  1988-04-01       Impact factor: 56.272

4.  Bone disease after jejuno-ileal bypass for obesity.

Authors:  J E Compston; L W Horton; M F Laker; A B Ayers; J S Woodhead; H J Bull; J C Gazet; T R Pilkington
Journal:  Lancet       Date:  1978-07-01       Impact factor: 79.321

5.  Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial.

Authors:  A Amery; W Birkenhäger; P Brixko; C Bulpitt; D Clement; M Deruyttere; A De Schaepdryver; C Dollery; R Fagard; F Forette
Journal:  Lancet       Date:  1985-06-15       Impact factor: 79.321

6.  Benefits and potential harm of lowering high blood pressure.

Authors:  J M Cruickshank; J M Thorp; F J Zacharias
Journal:  Lancet       Date:  1987-03-14       Impact factor: 79.321

7.  Evaluation of drug treatment in mild hypertension: VA-NHLBI feasibility trial. Plan and preliminary results of a two-year feasibility trial for a multicenter intervention study to evaluate the benefits versus the disadvantages of treating mild hypertension. Prepared for the Veterans Administration-National Heart, Lung, and Blood Institute Study Group for Evaluating Treatment in Mild Hypertension.

Authors: 
Journal:  Ann N Y Acad Sci       Date:  1978-03-30       Impact factor: 5.691

8.  Treatment of mild hypertension: a five year controlled drug trial. The Oslo study.

Authors:  A Helgeland
Journal:  Am J Med       Date:  1980-11       Impact factor: 4.965

9.  Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial.

Authors:  L Wilhelmsen; G Berglund; D Elmfeldt; T Fitzsimons; H Holzgreve; J Hosie; P E Hörnkvist; K Pennert; J Tuomilehto; H Wedel
Journal:  J Hypertens       Date:  1987-10       Impact factor: 4.844

10.  The Australian therapeutic trial in mild hypertension. Report by the Management Committee.

Authors: 
Journal:  Lancet       Date:  1980-06-14       Impact factor: 202.731
View more
  18 in total

1.  Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.

Authors: 
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

2.  Ambulatory blood pressure measurement in general practice.

Authors:  J P Cox; K O'Malley; E O'Brien
Journal:  Br J Gen Pract       Date:  1992-10       Impact factor: 5.386

3.  Cardiovascular risk management of hypertension and hypercholesterolaemia in the Netherlands: from unifactorial to multifactorial approach.

Authors:  I van Dis; J M Geleijnse; W M M Verschuren; D Kromhout
Journal:  Neth Heart J       Date:  2012-08       Impact factor: 2.380

4.  Risk assessment in the prevention of coronary heart disease: a policy statement. Coronary Prevention Group.

Authors: 
Journal:  Br J Gen Pract       Date:  1990-11       Impact factor: 5.386

Review 5.  Economic factors in the initiation of antihypertensive therapy.

Authors:  I Kawachi
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

Review 6.  Reserpine: a relic from the past or a neglected drug of the present for achieving cost containment in treating hypertension?

Authors:  G J Magarian
Journal:  J Gen Intern Med       Date:  1991 Nov-Dec       Impact factor: 5.128

7.  Relationship of plasma renin activity with caffeine intake and physical training in mild hypertensive men. HARVEST Study Group.

Authors:  P Palatini; C Canali; G R Graniero; G Rossi; R de Toni; M Santonastaso; M dal Follo; G Zanata; E Ferrarese; P Mormino; A C Pessina
Journal:  Eur J Epidemiol       Date:  1996-10       Impact factor: 8.082

8.  Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society.

Authors:  P Sever; G Beevers; C Bulpitt; A Lever; L Ramsay; J Reid; J Swales
Journal:  BMJ       Date:  1993-04-10

9.  Effects of diltiazem and metoprolol on blood pressure, adverse symptoms and general well-being. The Swedish Diltiazem-Metoprolol Multi-Centre Study Group.

Authors:  C Dahlöf; T Hedner; T Thulin; S Gustafsson; S O Olsson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 10.  The level at which blood pressure should be treated.

Authors:  J D Swales
Journal:  Cardiovasc Drugs Ther       Date:  1991-12       Impact factor: 3.727
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.